Skip to main navigation Skip to search Skip to main content

Cardiovascular Benefits of Icosapent Ethyl in Patients With and Without Atrial Fibrillation in REDUCE-IT

  • REDUCE-IT Investigators

Research output: Contribution to journal › Article › peer-review

26 Scopus citations

Fingerprint

Dive into the research topics of 'Cardiovascular Benefits of Icosapent Ethyl in Patients With and Without Atrial Fibrillation in REDUCE-IT'. Together they form a unique fingerprint.
Sort by

Keyphrases

Immunology and Microbiology